Kotak Healthcare Fund
Kotak Mutual Fund
Sectoral / Thematic Highly Differentiated As of 2026-05-31
Holdings
34
Concentrated
Top 10 weight
55%
Concentration
Active share
90%
Highly Differentiated
Equity
-
Asset allocation
Portfolio
4Sectors
20High-conviction bets
72%Top sector wt.
-Cash
Market-cap allocation
Large cap32%
Mid cap22%
Small cap45%
Asset allocation
Asset mix not available.
Top holdings
13.0%
6.2%
Divis Laboratories Ltd.EQUITY
6.0%5.4%
Cipla Ltd.EQUITY
5.0%Ami Organics LtdEQUITY
4.9%4.3%
4.2%
MANKIND PHARMA LTDEQUITY
3.2%3.1%
2.9%
2.9%
Lupin Ltd.EQUITY
2.6%ANTHEM BIOSCIENCES LTDEQUITY
2.4%2.4%
Aurobindo Pharma Ltd.EQUITY
2.3%Marksans Pharma LtdEQUITY
2.2%Ajanta Pharma Ltd.EQUITY
2.2%2.0%
Gland Pharma LimitedEQUITY
2.0%Laurus Labs LtdEQUITY
2.0%Alkem Laboratories Ltd.EQUITY
1.9%RUBICON RESEARCH LIMITEDEQUITY
1.8%ORCHID PHARMA LIMITEDEQUITY
1.7%CORONA REMEDIES LIMITEDEQUITY
1.7%1.5%
1.5%
Zydus Lifesciences Ltd.EQUITY
1.4%Triparty RepoCASH_EQUIVALENT
1.3%DR.Lal Pathlabs LtdEQUITY
1.3%LAXMI DENTAL LIMITEDEQUITY
1.2%INNOVA CAPTABS LTDEQUITY
1.2%1.1%
0.2%
Net Current Assets/(Liabilities)CASH_EQUIVALENT
-0.2%AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- Small-cap heavy (45%) - higher volatility.
- Concentrated in Pharmaceuticals and Biotechnology - watch sector risk.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in Sectoral / Thematic.
JioBlackRock Sector Rotation Fund290 holdings · 36% AS
Franklin India Multi-Factor Fund93 holdings · 84% AS
Bandhan Business Cycle Fund93 holdings · 65% AS
WhiteOak Capital Special Opportunities Fund90 holdings · 73% AS
UTI Quant Fund89 holdings · 66% AS
Axis India Manufacturing Fund86 holdings · 73% AS
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
72.4%
25.1%
1.2%
0.2%